Analysis of a focused set of compounds, blinded to name and structure, from Sponsor's internal compound collection for in vitro antiviral activity in UTMB's assay against SARS-CoV2/COVID-19

  • Shi, Pei-Yong (PI)

Project: Other project

Project Details

StatusFinished
Effective start/end date6/11/20 → 12/31/21

Funding

  • Merck Sharp & Dohme Corporation: $180,000.00